Glaucoma Surgery Devices

Glaucoma Surgery Devices

Global Glaucoma Surgery Devices Market to Reach US$8.3 Billion by 2030

The global market for Glaucoma Surgery Devices estimated at US$2.2 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 20.7% over the analysis period 2023-2030. Traditional Surgery Method, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Minimal Invasive Surgery Method segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$573.9 Million While China is Forecast to Grow at 26.2% CAGR

The Glaucoma Surgery Devices market in the U.S. is estimated at US$573.9 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 26.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.6% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.3% CAGR.

Global Glaucoma Surgery Devices Market - Key Trends and Drivers Summarized

How Are Glaucoma Surgery Devices Evolving to Meet Rising Demand?

Glaucoma surgery devices play a crucial role in the treatment of glaucoma, a leading cause of blindness worldwide. These devices are designed to reduce intraocular pressure (IOP) in patients where medications or less invasive treatments have failed. With advancements in ophthalmology, glaucoma surgery has evolved from traditional, invasive procedures to minimally invasive glaucoma surgeries (MIGS), which reduce recovery times and improve patient outcomes. Devices such as shunts, stents, and laser-based systems are used to drain fluid and lower IOP, preventing further damage to the optic nerve. As the aging population grows and awareness of glaucoma increases, the demand for effective surgical treatments is on the rise.

What Are the Major Segments and Applications of Glaucoma Surgery Devices?

The glaucoma surgery devices market is segmented by product type, including drainage implants, stents, and laser devices. Drainage implants, such as aqueous shunts, are used in patients with advanced glaucoma to create new drainage pathways for fluid. MIGS devices, including tiny stents that are implanted in the eye, are gaining popularity due to their less invasive nature and lower risk profiles. Laser systems, which include selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), are used to improve fluid outflow. The market is also segmented by end-users, such as hospitals, ambulatory surgical centers, and ophthalmic clinics. North America and Europe dominate the market due to advanced healthcare infrastructure and high glaucoma prevalence, while Asia-Pacific is witnessing rapid growth as healthcare access improves.

How Are Technological Innovations Impacting Glaucoma Surgery Devices?

Technological advancements are revolutionizing glaucoma surgery devices, particularly in the development of minimally invasive solutions. MIGS devices are at the forefront of innovation, offering safer and more effective options for glaucoma patients who are not candidates for traditional surgery. These devices reduce trauma to the eye and speed up recovery times, making them increasingly popular among ophthalmologists and patients alike. Advances in laser technologies are also enhancing the precision and effectiveness of glaucoma surgeries, while smart implants that monitor intraocular pressure in real-time are poised to transform post-surgical care. Furthermore, artificial intelligence and robotics are beginning to enter the field, offering new possibilities for precision surgeries and outcome prediction.

What Factors Are Driving the Growth in the Glaucoma Surgery Devices Market?

The growth in the glaucoma surgery devices market is driven by several factors, including the rising prevalence of glaucoma, particularly among the aging population. Technological advancements in minimally invasive surgical techniques are making glaucoma surgery safer and more accessible, driving increased adoption. Growing awareness about early diagnosis and treatment of glaucoma is expanding the market for surgical devices as patients seek more effective solutions. Additionally, increased healthcare expenditure and favorable reimbursement policies in developed regions are supporting market growth. In emerging markets, improved healthcare infrastructure and access to advanced ophthalmic treatments are further fueling the demand for glaucoma surgery devices.

Select Competitors (Total 42 Featured) -

• Abbott Medical Optics
• Alcon, Inc.
• Allergan Plc.
• ASICO
• Carl Zeiss Meditec AG
• Glaukos Corporation
• Iridex Corporation
• Johnson & Johnson
• Katalyst Surgical
• Lumenis Ltd.
• Nidek Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Sight Sciences, Inc.
• Ziemer Ophthalmic Systems AG

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.